These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

574 related items for PubMed ID: 18049474

  • 1. The design of drugs for HIV and HCV.
    De Clercq E.
    Nat Rev Drug Discov; 2007 Dec; 6(12):1001-18. PubMed ID: 18049474
    [Abstract] [Full Text] [Related]

  • 2. HCV and HIV: a tale of two viruses.
    Sherman KE.
    Rev Gastroenterol Disord; 2004 Dec; 4 Suppl 1():S48-54. PubMed ID: 15185718
    [Abstract] [Full Text] [Related]

  • 3. HIV and hepatitis C coinfection.
    Matthews GV, Dore GJ.
    J Gastroenterol Hepatol; 2008 Jul; 23(7 Pt 1):1000-8. PubMed ID: 18707597
    [Abstract] [Full Text] [Related]

  • 4. Antiviral combination therapy for treatment of chronic hepatitis B, hepatitis C, and human immunodeficiency virus infection.
    Hofmann WP, Soriano V, Zeuzem S.
    Handb Exp Pharmacol; 2009 Jul; (189):321-46. PubMed ID: 19048206
    [Abstract] [Full Text] [Related]

  • 5. Interaction between HIV-1 and HCV infections: towards a new entity?
    Winnock M, Salmon-Céron D, Dabis F, Chêne G.
    J Antimicrob Chemother; 2004 Jun; 53(6):936-46. PubMed ID: 15117928
    [Abstract] [Full Text] [Related]

  • 6. New therapeutic options for hepatitis C.
    Waters L, Nelson M.
    Curr Opin Infect Dis; 2006 Dec; 19(6):615-22. PubMed ID: 17075339
    [Abstract] [Full Text] [Related]

  • 7. Peptidomimetic therapeutic agents targeting the protease enzyme of the human immunodeficiency virus and hepatitis C virus.
    Tsantrizos YS.
    Acc Chem Res; 2008 Oct; 41(10):1252-63. PubMed ID: 18681464
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. HIV and hepatitis C co-infection.
    Jones R, Dunning J, Nelson M.
    Int J Clin Pract; 2005 Sep; 59(9):1082-7. PubMed ID: 16115185
    [Abstract] [Full Text] [Related]

  • 12. HCV versus HIV drug discovery: Déjà vu all over again?
    Watkins WJ, Desai MC.
    Bioorg Med Chem Lett; 2013 Apr 15; 23(8):2281-7. PubMed ID: 23489621
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Evaluation systems for anti-HCV drugs.
    Moriishi K, Matsuura Y.
    Adv Drug Deliv Rev; 2007 Oct 10; 59(12):1213-21. PubMed ID: 17720275
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Hepatitis C virus virology and new treatment targets.
    Meier V, Ramadori G.
    Expert Rev Anti Infect Ther; 2009 Apr 10; 7(3):329-50. PubMed ID: 19344246
    [Abstract] [Full Text] [Related]

  • 17. Novel hepatitis C drugs in current trials.
    Kronenberger B, Welsch C, Forestier N, Zeuzem S.
    Clin Liver Dis; 2008 Aug 10; 12(3):529-55, viii. PubMed ID: 18625427
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. [HIV and HCV infections--clinical implications].
    Pawłowska M, Halota W, Grabczewska E.
    Przegl Epidemiol; 2004 Aug 10; 58 Suppl 1():71-5. PubMed ID: 15807161
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 29.